The interaction of eltanolone and fentanyl with special reference to logistic regression analysis

Anesthesia and Analgesia

Volumn 87, Issue 4, 1998, Pages 967-972

  Bowen, Philip J ^a   Windsor, Alastair ^a   Flaishon, Ron ^a   Sebel, Peter S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ELTANOLONE; FENTANYL; HYPNOTIC AGENT;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; HUMAN; HYPNOSIS; IMMOBILIZATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SEDATION; SKIN INCISION; UNCONSCIOUSNESS;

ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; ANESTHESIA; ANESTHETICS; ANESTHETICS, COMBINED; CONSCIOUSNESS; DRUG INTERACTIONS; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; PAIN THRESHOLD; PREGNANOLONE; REGRESSION ANALYSIS;

EID: 0031715575     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199810000-00041     Document Type: Article

References (15)

1. Mertens MJ, Vuyk J, Parivar K, et al. The pharmacodynamic interaction between eltanolone and alfentanil for lower abdominal surgery in female patients [abstract]. Br J Anaesth 1997;78: A315.
2. McClain DA, Hug CC. Intravenous fentanyl kinetics. Clin Pharmacol Ther 1980;28:106-14.
3. Scott JC, Stanski DR. Decreased fentanyl and alfentanil dose requirements with age: a simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 1987;240: 159-66.
4. Hering W, Ihmsen H, Langer H, et al. Pharmacokinetic-pharmacodynamic modeling of the new steroid hypnotic eltanolone in healthy volunteers. Anesthesiology 1996;85:1290-9.
5. Dixon WJ. The up-and-down method for small samples. Am Stat Assoc J 1965;60:967-78.
6. Waud DR. On biological assays involving quantal responses. J Pharmacol Exp Ther 1972;183:577-607.
7. Shafer SL, Varvel JR, Aziz N, Scott JC. Pharmacokinetics of fentanyl administered by computer-controlled infusion pump. Anesthesiology 1990;73:1091-102.
8. Varvel J, Donoho DL, Shafer SL. Measuring the predictive performance of computer-controlled infusion pumps. J Pharmacokinet Biopharm 1992;20:63-94.
9. Kanto J, Gepts E. Pharmacokinetic implications for the clinical use of propofol. Clin Pharmacokinet 1989;17:308-26.
10. Greco WR, Bravo G, Parsons JC. The search for synergy: a critical review from a response surface perspective. Pharmacol Rev 1995;47:331-85.
11. Sebel PS, Glass PSA, Fletcher JE, et al. Reduction of the MAC of desflurane with fentanyl. Anesthesiology 1992;76:52-9.
12. McEwan AI, Smith C, Dyar O, et al. Isoflurane minimum alveolar concentration reduction by fentanyl. Anesthesiology 1993; 78:864-9.
13. Westmoreland CL, Sebel PS, Cropper A. Fentanyl or alfentanil decreases the minimum alveolar anesthetic concentration of isoflurane in surgical patients. Anesth Analg 1994;78:23-8.
14. 50 of propofol for loss of consciousness and skin incision. Anesthesiology 1994;81:820-8.
15. Telford RJ, Glass PSA, Goodman D, Jacobs JR. Fentanyl does not alter the "sleep" plasma concentration of thiopental. Anesth Analg 1992;75:523-9.